We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.39%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$7.43B
AUM Growth
+$757M
Cap. Flow
+$285M
Cap. Flow %
3.83%
Top 10 Hldgs %
21.69%
Holding
281
New
28
Increased
104
Reduced
67
Closed
44

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$124M
2
MDT icon
Medtronic
MDT
+$67.1M
3
BDX icon
Becton Dickinson
BDX
+$51.8M
4
RTX icon
RTX Corp
RTX
+$51.1M
5
HUM icon
Humana
HUM
+$44.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$82.1M
2
BAX icon
Baxter International
BAX
+$49.3M
3
INCY icon
Incyte
INCY
+$42.4M
4
SYK icon
Stryker
SYK
+$34.6M
5
MD icon
Pediatrix Medical
MD
+$33.9M

Sector Composition

Rank Sector Weight
1 Financials 23.39%
2 Healthcare 23.32%
3 Technology 19.99%
4 Communication Services 10.16%
5 Industrials 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOG icon
1
Alphabet (Google) Class C
GOOG
$3.9T
$233M 3.14%
5,136,460
-261,120
-5% -$12M
META icon
2
Meta Platforms (Facebook)
META
$1.51T
$233M 3.14%
1,544,454
+71,958
+5% +$10.7M
AAPL icon
3
Apple
AAPL
$4.89T
$214M 2.89%
5,954,328
+11,756
+0.2% +$435K
JNJ icon
4
Johnson & Johnson
JNJ
$634B
$150M 2.01%
1,131,752
+971,752
+607% +$124M
CB icon
5
Chubb
CB
$140B
$144M 1.93%
987,361
+16,006
+2% +$2.25M
MSFT icon
6
Microsoft
MSFT
$2.84T
$141M 1.9%
2,045,427
-103,250
-5% -$7.09M
ELV icon
7
Elevance Health
ELV
$81.9B
$130M 1.75%
691,865
-11,891
-2% -$2.14M
MDT icon
8
Medtronic
MDT
$107B
$126M 1.7%
1,423,080
+795,339
+127% +$67.1M
MKL icon
9
Markel Group
MKL
$25B
$120M 1.62%
123,384
+1,725
+1% +$1.67M
BRK.B icon
10
Berkshire Hathaway Class B
BRK.B
$1.07T
$120M 1.61%
706,635
+25,002
+4% +$4.16M
ACGL icon
11
Arch Capital
ACGL
$36.1B
$113M 1.52%
3,642,441
+26,109
+0.7% +$828K
GOOGL icon
12
Alphabet (Google) Class A
GOOGL
$3.91T
$107M 1.43%
2,291,940
-276,940
-11% -$13M
C icon
13
Citigroup
C
$222B
$104M 1.4%
1,551,670
-11,043
-0.7% -$677K
DLB icon
14
Dolby
DLB
$4.72B
$89M 1.2%
1,818,467
+132,844
+8% +$6.77M
CELG
15
DELISTED
Celgene Corp
CELG
$88.3M 1.19%
680,041
+140,041
+26% +$17.2M
AMZN icon
16
Amazon
AMZN
$2.5T
$87.5M 1.18%
1,808,200
+25,140
+1% +$1.2M
MRSH
17
Marsh
MRSH
$86.3B
$86.5M 1.16%
1,109,000
+31,800
+3% +$2.4M
AAPL icon
18
CALL
Apple
AAPL
$4.89T
$86.4M 1.16%
2,400,000
– –
BABA icon
19
Alibaba
BABA
$269B
$86.3M 1.16%
612,279
+99,690
+19% +$12.3M
V icon
20
Visa
V
$677B
$86.2M 1.16%
919,071
-54,405
-6% -$5.05M
VR
21
DELISTED
Validus Hold Ltd
VR
$83.9M 1.13%
1,614,588
+135,812
+9% +$7.32M
AME icon
22
Ametek
AME
$55.5B
$82.9M 1.12%
1,368,362
+166,007
+14% +$9.78M
PEP icon
23
PepsiCo
PEP
$186B
$79.9M 1.07%
691,451
– –
CNQ icon
24
Canadian Natural Resources
CNQ
$96.9B
$74.6M 1%
4,566,026
+748,570
+20% +$11.3M
AON icon
25
Aon
AON
$77.3B
$71.8M 0.97%
540,102
+8,850
+2% +$1.12M
1
2 3 4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Polar Capital held 281 positions worth $7.43B, up 11% from $6.67B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Polar Capital deployed $285M of net new capital in Q2 2017, opening 28 new positions and adding to 104 existing holdings. Its largest new stake was RTX Corp: 681,946 shares worth $52.4M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $82.1M trimmed.

  • Polar Capital's largest Q2 2017 buy was RTX Corp: 681,946 shares worth $52.4M.
  • Polar Capital added most to Johnson & Johnson in Q2 2017, an estimated $124M increase.
  • Polar Capital's biggest Q2 2017 reduction was Merck, cutting an estimated $82.1M.
  • Polar Capital fully exited Baxter International in Q2 2017, selling an estimated $49.3M.
  • Polar Capital's ten largest holdings make up 22% of its $7.43B portfolio in Q2 2017.
  • Polar Capital opened 28 new positions and closed 44 in Q2 2017.
  • Polar Capital's portfolio value rose 11% quarter-over-quarter to $7.43B.

Based on Polar Capital's 13F filing for Q2 2017, filed 14 Aug 2017.